Literature DB >> 2363690

A comparative study of the N-linked oligosaccharide structures of human IgG subclass proteins.

R Jefferis1, J Lund, H Mizutani, H Nakagawa, Y Kawazoe, Y Arata, N Takahashi.   

Abstract

Quantitative oligosaccharide profiles were determined for each of 18 human IgG paraproteins representing the four subclasses. Each paraprotein exhibits a unique profile that may be substantially different from that observed for polyclonal IgG. The IgG2 and some IgG3 proteins analysed exhibit a predominance of oligosaccharide moieties having galactose on the Man(alpha 1----3) arm rather than the Man(alpha 1----6) arm; it was previously held that galactosylation of the Man(alpha 1----6) arm is preferred, as observed for IgG1, IgG4 and polyclonal IgG. An IgG4 protein is reported that has galactosylated Man(alpha 1----3) and Man(alpha 1----6) arms on both Fc-localized carbohydrate moieties; previous findings suggested that such fully glycosylated structures could not be accommodated within the internal space of the C gamma 2 domains. Unusual monoantennary oligosaccharides present in IgG2 and IgG3 proteins were isolated and their structures determined.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2363690      PMCID: PMC1131471          DOI: 10.1042/bj2680529

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  17 in total

1.  Carbohydrates in protein. 4. The determination of mannose in hen's-egg albumin by radioisotope dilution.

Authors:  C FRANCOIS; R D MARSHALL; A NEUBERGER
Journal:  Biochem J       Date:  1962-05       Impact factor: 3.857

2.  Structural studies of two ovalbumin glycopeptides in relation to the endo-beta-N-acetylglucosaminidase specificity.

Authors:  T Tai; K Yamashita; M Ogata-Arakawa; N Koide; T Muramatsu; S Iwashita; Y Inoue; A Kobata
Journal:  J Biol Chem       Date:  1975-11-10       Impact factor: 5.157

3.  The effect of aglycosylation on the binding of mouse IgG to staphylococcal protein A.

Authors:  R J Leatherbarrow; R A Dwek
Journal:  FEBS Lett       Date:  1983-12-12       Impact factor: 4.124

4.  The three-dimensional structure of the carbohydrate within the Fc fragment of immunoglobulin G.

Authors:  B J Sutton; D C Phillips
Journal:  Biochem Soc Trans       Date:  1983-04       Impact factor: 5.407

5.  Effector functions of a monoclonal aglycosylated mouse IgG2a: binding and activation of complement component C1 and interaction with human monocyte Fc receptor.

Authors:  R J Leatherbarrow; T W Rademacher; R A Dwek; J M Woof; A Clark; D R Burton; N Richardson; A Feinstein
Journal:  Mol Immunol       Date:  1985-04       Impact factor: 4.407

6.  Biological significance of carbohydrate chains on monoclonal antibodies.

Authors:  M Nose; H Wigzell
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

7.  Reexamination of the pyridylamination used for fluorescence labeling of oligosaccharides and its application to glycoproteins.

Authors:  S Hase; T Ibuki; T Ikenaka
Journal:  J Biochem       Date:  1984-01       Impact factor: 3.387

8.  The release of carbohydrate moieties from human fibrinogen by almond glycopeptidase without alteration in fibrinogen clottability.

Authors:  H Nishibe; N Takahashi
Journal:  Biochim Biophys Acta       Date:  1981-10-13

9.  Structural and numerical variations of the carbohydrate moiety of immunoglobulin G.

Authors:  T Mizuochi; T Taniguchi; A Shimizu; A Kobata
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

10.  Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG.

Authors:  R B Parekh; R A Dwek; B J Sutton; D L Fernandes; A Leung; D Stanworth; T W Rademacher; T Mizuochi; T Taniguchi; K Matsuta
Journal:  Nature       Date:  1985 Aug 1-7       Impact factor: 49.962

View more
  35 in total

1.  Second Jenner international glycoimmunology meeting.

Authors: 
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

2.  An innovative approach for the characterization of the isoforms of a monoclonal antibody product.

Authors:  Shanmuuga Sundaram; Alice Matathia; Jun Qian; Jingming Zhang; Ming-Ching Hsieh; Tun Liu; Richard Crowley; Babita Parekh; Qinwei Zhou
Journal:  MAbs       Date:  2011-11-01       Impact factor: 5.857

3.  Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity.

Authors:  Falk Nimmerjahn; Robert M Anthony; Jeffrey V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-07       Impact factor: 11.205

4.  Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc.

Authors:  Robert M Anthony; Falk Nimmerjahn; David J Ashline; Vernon N Reinhold; James C Paulson; Jeffrey V Ravetch
Journal:  Science       Date:  2008-04-18       Impact factor: 47.728

5.  Rheumatoid factors: where are we now?

Authors:  A I Soltys; J S Axford; B J Sutton
Journal:  Ann Rheum Dis       Date:  1997-05       Impact factor: 19.103

6.  Processing of complex N-glycans in IgG Fc-region is affected by core fucosylation.

Authors:  Alexandra Castilho; Clemens Gruber; Andreas Thader; Chris Oostenbrink; Maria Pechlaner; Herta Steinkellner; Friedrich Altmann
Journal:  MAbs       Date:  2015       Impact factor: 5.857

7.  Neutralization of mitogenic lectins by intravenous immunoglobulin (IVIg) prevents T cell activation: does IVIg really have a direct effect on T cells?

Authors:  L Padet; I St-Amour; É Aubin; R Bazin
Journal:  Clin Exp Immunol       Date:  2011-12       Impact factor: 4.330

8.  Crystallization of a complex between the Fab fragment of a human immunoglobulin M (IgM) rheumatoid factor (RF-AN) and the Fc fragment of human IgG4.

Authors:  M K Sohi; A L Corper; T Wan; M Steinitz; R Jefferis; D Beale; M He; A Feinstein; B J Sutton; M J Taussig
Journal:  Immunology       Date:  1996-08       Impact factor: 7.397

Review 9.  Analytical and Functional Aspects of Antibody Sialylation.

Authors:  Johannes Stadlmann; Martin Pabst; Friedrich Altmann
Journal:  J Clin Immunol       Date:  2010-05       Impact factor: 8.317

10.  Improving effector functions of antibodies for cancer treatment: Enhancing ADCC and CDC.

Authors:  Akito Natsume; Rinpei Niwa; Mitsuo Satoh
Journal:  Drug Des Devel Ther       Date:  2009-09-21       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.